Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia

导出原文传递

翻译打印收藏纠错

作者： Treon, Steven P. ^[1] ; Meid, Kirsten ^[2] ; Gustine, Joshua ^[3] ; Yang, Guang ^[4] ; Xu, Lian ; Liu, Xia ; Patterson, Christopher J. ; Hunter, Zachary R. ; Branagan, Andrew R. ; Laubach, Jacob P. ; Ghobrial, Irene M. ; Palomba, M. Lia ; Advani, Ranjana ; Castillo, Jorge J.

作者单位： Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, M548,450 Brookline Ave, Boston, MA ^[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA ^[2] Harvard Med Sch, Dept Med, Boston, MA 02115 USA ^[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA ^[4]

发布时间 2021-05-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Journal of Clinical Oncology

2021年39卷6期

565-+页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia

Journal of Clinical Oncology

相似文献

Journal of Clinical Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia

Journal of Clinical Oncology

相似文献

Journal of Clinical Oncology

相关期刊

检索历史清除